TNR States, Global Spatial OMICS Market was Valued USD 263.4 Mn in 2022, with an Estimated CAGR of 11.3% by 2031.

Spatial OMICS is a collective term for many technologies that allow OMICS data to be superimposed on tissue pictures. These approaches, in addition to identifying molecular subpopulations of cells, offer knowledge on the spatial localization of the identified subpopulations within the tissue of origin. Furthermore it analyzes their proximity to each other and the extracellular matrix, blood vessels, and other tissue components.

Genomics, for example, examines the entire genome, whereas transcriptomics reads the entire RNA and proteomics examines the protein composition. Spatial OMICS now integrates molecular analysis with geographical information on the location of cells inside tissues. As a result, this technology provides a strong tool for understanding critical systems such as tissue organisation and cell control.

Global Spatial OMICS Market Revenue & Forecast, (US$ Million), 2015 – 2031

Global Spatial OMICS Market Future

Significant advancements in next-generation sequencing and imaging-based methods have resulted in a revolution in the capacity to assess gene expression in tissue slices while maintaining cellular organization. When paired with single-cell RNA-seq, spatial OMICS techniques give a precise picture of cellular heterogeneity and tissue organisation. Moreover spatial OMICS is expected to become more widely adopted across various research areas, including cancer biology, neuroscience, and developmental biology, immunology, and drug discovery.  Its integration into clinical diagnostics and personalized medicine is a significant future prospect. Spatially resolved molecular profiling could aid in disease diagnosis, treatment selection, and monitoring patient responses to therapies leading to the growth of spatial OMICS market.

Report Coverage and Deliverables

Spatial transcriptomics is a method that integrates gene expression studies with geographical context of cells. The spatial organisation of cell populations can be determined by mapping gene expression across tissue. Current spatial transcriptomic techniques, on the other hand, lack genuine single-cell resolution, depending on region of interest (ROI) or spot-based capture methods that cannot capture cellular variety properly. Nonetheless, transcriptomics is a potent research tool for discovery. The ability to profile hundreds of thousands of cells and thousands of genes in a single experiment allows for unbiased investigation of the tissue microenvironment, making this method extremely complimentary to imaging-based spatial proteomics.

Spatial genomics, in particular, has shown to be a vital instrument in disease research. Despite the fact that all human cells have the same genetic information, it is arranged and packed differently. This can influence which genes in each cell are translated into proteins. For example, spatial genomics may be used to isolate genetic variation in non-coding portions of the genome that causes a cell to become malignant. Furthermore, as the costs of DNA sequencing and lab automation fall, spatial genomics is gaining traction, with major centres including the United States, the United Kingdom, and Sweden.

Spatial OMICS market in North America, particularly in the United States and Canada, has seen significant growth and innovation in recent years. Leading universities and research institutions in North America are actively engaged in spatial OMICS research. They conduct studies across various fields, including cancer biology, neuroscience, developmental biology, and immunology, using spatial OMICS techniques to gain insights into complex biological processes. Major pharmaceutical and biotechnology companies based in North America are integrating spatial OMICS into their drug discovery and development pipelines. This includes applications in target identification, biomarker discovery, and assessing drug effects at the cellular level.

Competitive Landscape

The competitive landscape of spatial OMICS market is marked by innovation, collaboration, and rapid developments in technology and data analysis tools. Startups are contributing to the introduction of novel techniques and platforms, while established players are expanding their portfolios. Academic institutions and collaborative initiatives are fostering knowledge exchange and interdisciplinary research, further propelling the field’s advancement. As the spatial OMICS market continues to evolve, new entrants and developments are expected to shape its landscape further.

Major players operating in the global spatial OMICS market are:  

• 10x Genomics
• Agilent Technologies Inc
• Akoya Biosciences
• Bio-Techne
• CD Genomics
• Ilumina Inc
• Indica Labs, Inc.
• Miltenyi Biotec
• NanoString Technologies Inc
• Owkin
• RareCyte, Inc.
• S2 Genomics, Inc.
• SciLifeLab
• Ultivue Inc.
• Visiopharm A/S
• ZEISS
• Other Industry Participants

Global Spatial OMICS Market Report Coverage

Global Spatial OMICS Market

By Techniques

• Spatial Transcriptomics
  • Immunohistochemistry (IHC)
  • Fluorescence In-Situ Hybridization (FISH)
  • Sequencing
    • In Situ Sequencing (ISS)
    • Microdissection Sequencing
    • Others
  • In-Situ capturing
  • Microscopy based RNA imaging techniques
    • Padlock Probes & Rolling Circle Amplification
    • Single Molecule RNS Fluorescence In-Situ Hybridization (smFISH)
    • Branched DNA probes
  • Transcriptome In-Vivo Analysis (TIVA)
• Spatial Genomics
  • Fluorescence in situ Sequencing
  • Fluorescence Microscopy-based
  • Others
• Spatial proteomics
• Spatial metabolomics
• Spatial multi-omics
• Others

By Offerings

• Products
• Solutions
• Consumables

By Application

• Biomarker Discovery
• Drug Development
• Cancer Research
• Infectious Diseases
• Immunology
• Metabolic Studies
• Others

By Sample Type

• Frozen tissues
• FFPE tissues

By End Users

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

.